查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1522733

全球数位糖尿病管理市场评估:按产品和服务,设备类型,患者类型,最终用户,地区,机会,预测2017-2031年

Digital Diabetes Management Market Assessment, By Products and Services, By Device Type, By Patient Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 230 Pages | 商品交期: 3-5个工作天内

价格

全球数位糖尿病管理市场规模预计将从 2023 年的 183.6 亿美元成长到 2031 年的 437.6 亿美元，2024-2031 年预测期间复合年增长率为 11.47%。糖尿病患者数量的增加、疾病监测的重要性日益增加、远端患者监测的日益普及、新产品开发投资的增加以及市场主要参与者之间的合作不断增加，推动了市场的成长。

数位糖尿病管理产品和服务的快速采用也归因于它们的易用性。数位糖尿病管理产品和服务使医生和患者之间能够定期沟通并持续监测血糖数据，从而使医疗保健专业人员和护理管理者能够提高为患者提供的护理品质并改善他们的健康结果。

糖尿病负担的增加以及对能够以简化的方式管理病情的先进数位解决方案的需求不断增加，是推动各国政府投资糖尿病管理数位工具和服务的主要因素之一。2023年，韩国政府将启动全国综合生物大数据项目，收集参与者的数据，瞭解新兴趋势，并采取有效措施改善病患的治疗结果。此外，加拿大政府于 2021 年宣布将投资 3,500 万美元用于糖尿病预防，其中 2,500 万美元用于建立国家糖尿病框架以及研究和监测。这些举措和支持措施预计将支持市场扩张并推动对数位糖尿病管理产品和服务的需求。

该报告探讨了全球数位糖尿病管理市场，提供了市场概述、产品/服务趋势、设备类型、患者类型、最终用户、地区以及参与市场的公司概况。

目录

第1章 研究方法论

第2章 专案范围与定义

第3章 执行摘要

第4章 2017-2031 年全球数位糖尿病管理市场展望

  • 市场规模及预测
  • 按产品/服务
  • 按设备类型
  • 依患者类型
  • 按最终用户
  • 按地区
  • 按公司划分的市占率 (%)，2023 年

第5章 全球数位化糖尿病管理市场展望（按地区，2017-2031）

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东/非洲

第6章 市场测绘，2023 年

第7章 宏观环境与产业结构

  • 供需分析
  • 进出口分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第8章 市场动态

第9章 监理架构与创新

第10章 主要与企业状况

第11章 价格分析

第12章 案例研究

第13章 主要进入者展望

  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Medtronic
  • B. Braun SE
  • Tandem Diabetes Care, Inc.
  • LifeScan, Inc.
  • Insulet Corporation
  • Bayer AG
  • Ascensia Diabetes Care Holdings AG

第14章 战略建议

第15章 查询及免责声明

Product Code: MX11669

Global digital diabetes management market is projected to witness a CAGR of 11.47% during the forecast period 2024-2031F, growing from USD 18.36 billion in 2023 to USD 43.76 billion in 2031F. The market's growth is bolstered by the rising cases of diabetes, increasing emphasis on disease surveillance, growing popularity of remote patient monitoring, rising investments towards novel product development, and increasing collaborations between the key players of the market.

The rapid adoption of digital diabetes management products and services can also be attributed to the ease of use associated with them. They allow for communication between physicians and patients on a regular basis and the constant monitoring of the glycemic data allows healthcare professionals and caretakers to improve health outcomes by enhancing the quality of care provided to the patients.

Additionally, the introduction of novel technologies by various companies bolsters the global digital diabetes management market size. In August 2023, Welldoc Platform announced that they had received 510 (k) FDA clearance for their BlueStar digital diabetes management platform. This clearance allowed BlueStar to ensure that the bolus insulin dose was provided as per the recommendations on the basis of the continuous glucose readings. This development is expected to aid patients who require multiple injections of insulin on a daily basis to manage diabetes. Additionally, in July 2023, Better Therapeutics, Inc. also received authorization from the Food and Drug Administration for AspyreRx, a prescription-only digital therapeutic treatment used for providing cognitive behavioral therapy to patients suffering from type 2 diabetes who are 18 or older. Such developments and approvals are expected to boost the global digital diabetes management market demand and provide lucrative growth opportunities to the market.

Increasing Governmental Efforts Support Market Expansion

The growing burden of diabetes and the increasing requirement for advanced digital solutions that allow the management of the condition in a streamlined manner are some of the major factors because of which various governments are investing in digital tools and services for managing diabetes. In 2023, the government of South Korea launched the Nation Integrated Bio-big Data Project to collect data from the participants to understand the new trends and implement effective measures to enhance patient outcomes. Additionally, in 2021 the Government of Canada announced an investment of USD 35 million in diabetes prevention, of which USD 25 million were promised for the development of a national framework for diabetes as well as towards research and surveillance. Such initiatives and supportive measures are expected to support the expansion of the market and boost the demand for digital diabetes management products and services.

Rising Cases of Diabetes Bolster Market Demand

The rise in the number of cases of diabetes in various regions across the globe due to increasing obesity, genetics, and sedentary lifestyles is propelling the requirement for digital diabetes management devices and services. According to the estimates of the World Health Organization (WHO), approximately 422 million individuals across the globe are living with diabetes. This increase is augmenting the efforts of various healthcare companies and academic institutions towards the development of digital diabetes management products as the self-monitoring of blood glucose (SMBG), continuous glucose monitoring (CGM), mHealth apps, and decision support systems aid in reducing glycemic variability, HbA1c levels, and enhance self-management of diabetes to ensure timely interventions in case of hypoglycemic events. The data collected from digital diabetes management devices have the potential of detecting hypoglycemia and ensures the safety and efficacy of digital support systems and workflow, thus boosting the market's expansion.

North America Accounts for Significant Market Share

The growth of the market in North America is supported by the rising cases of diabetes in the region, strong presence of key market players, and high acceptance of novel digital disease management solutions. Digital diabetes management devices aid healthcare providers in visualizing trends in blood glucose levels, generating reports, analyzing collected data, and ensuring medication adherence. Due to the rising cases of diabetes in the region, the reliance on digital devices and services has significantly increased to ensure optimal care is provided to the patients and allow the effective management of the disease. According to the estimates of the US Centers for Disease Control and Prevention, in 2021 approximately 29.7 million individuals, accounting for 8.9% of the population of the United States, had been diagnosed with diabetes.

The increasing accessibility of digital diabetes management services and products coupled with the rising efforts of the companies based in the regions towards the development of novel solutions is further propelling the expansion of the market in North America. In October 2023, Insulet Corporation announced that their Omnipod 5 App for iPhone has received 510 (k) clearance from the FDA. With this clearance, Insulet became the first company known for offering automated insulin delivery systems that are compatible with iOS and Android smartphones. Such developments are expected to boost the accessibility of digital diabetes management solutions, augmenting the expansion of the market in the region.

Wearable Devices Expected to Account Significant Share of the Market

The growth of the segment can be attributed to the different advantages associated with their usage, including automated insulin delivery and the availability of real-time insights related to blood glucose levels. Additionally, artificial intelligence (AI) tools and advanced analytics can also aid healthcare professionals in predicting blood glucose fluctuations and analyzing data, allowing them to suggest personalized treatment options and determine various risk factors and complications associated with diabetes.

Furthermore, the continuous efforts of various health technology companies towards the development of wearable devices with advanced technologies is another major factor supporting the expansion of the segment. In March 2024, Dexcom, Inc. received clearance from the US Food and Drug Administration for Stelo. This wearable glucose biosensor is worn by the patients on the back of their arms and delivers data directly on their smartphones. With the help of constant health monitoring and wearable devices, valuable insights are provided to physicians and patients to facilitate preventive measures and early interventions for potential chronic situations.

Future Market Scenario (2024-2031F)

According to the global digital diabetes management market analysis, the growing popularity of remote patient monitoring and increased acceptance of digital devices for the management of various diseases and disorders is anticipated to provide lucrative growth opportunities to the market. The rising cases of diabetes are also expected to bolster the market demand. According to the estimates of The Lancet, approximately 1.3 billion individuals are expected to have diabetes by 2050.

Personalization of healthcare with the help of digital devices is also expected to improve patient access to different treatments and allow them to effectively manage long-term diseases such as diabetes. Additionally, with the help of data analysis, digital diabetes management solutions are expected to aid in enhancing the understanding of the requirements of the patients as well as strengthen partnerships with digital experts. Furthermore, AI is expected to play a crucial role in providing personalized diabetes management by analyzing the glucose data of millions of individuals round-the-clock, which in turn can support decision-making for individual patients and ensure that they are provided with recommendations suggested to their requirements. Thus, boosting the expansion of the market in the coming years.

Key Players Landscape and Outlook

The rising collaborations between key players of the market to boost the development and introduction of novel products and technologies in different geographical locations is supporting the global digital diabetes management market growth. In July 2024, Abbott and Dexcom announced that they will be launching their continuous glucose monitor in the coming months of 2024. The devices are expected to aid the companies in reaching approximately 25 million individuals in the United States that are suffering from Type 2 diabetes and do not take insulin, 85 million with undiagnosed pre-diabetes, and 15 million with pre-diabetes.

In March 2023, Roche Diabetes Care Japan Co., Ltd. and Astellas Pharma Inc. announced that they had entered in an agreement to commercialize and develop Roche's Accu-Chek Guide Me blood glucose monitoring system. The development of advanced digital solutions for management of diabetes is gaining traction in Japan due to the rising cases of the disease in the country, thus supporting the growth of the market.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Digital Diabetes Management Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Products and Services
    • 4.2.1. Devices
      • 4.2.1.1. Smart Insulin Pens
      • 4.2.1.2. Smart Glucose Meters
      • 4.2.1.3. Smart Insulin Pumps
      • 4.2.1.4. Continuous Blood Glucose Monitoring (CGM) System
    • 4.2.2. Data Management Software and Platform
    • 4.2.3. Diabetes Applications
      • 4.2.3.1. Obesity and Diet Management Apps
      • 4.2.3.2. Diabetes and Blood Glucose Tracking Apps
    • 4.2.4. Services
  • 4.3. By Device Type
    • 4.3.1. Handheld Devices
    • 4.3.2. Wearable Devices
  • 4.4. By Patient Type
    • 4.4.1. Type 1 Diabetes
    • 4.4.2. Type 2 Diabetes
  • 4.5. By End-user
    • 4.5.1. Home Healthcare
    • 4.5.2. Hospitals and Specialty Clinics
    • 4.5.3. Academic and Research Institutes
    • 4.5.4. Others
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. South America
    • 4.6.3. Europe
    • 4.6.4. Asia-Pacific
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Digital Diabetes Management Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Products and Services
      • 5.1.2.1. Devices
        • 5.1.2.1.1. Smart Insulin Pens
        • 5.1.2.1.2. Smart Glucose Meters
        • 5.1.2.1.3. Smart Insulin Pumps
        • 5.1.2.1.4. Continuous Blood Glucose Monitoring (CGM) System
      • 5.1.2.2. Data Management Software and Platform
      • 5.1.2.3. Diabetes Applications
        • 5.1.2.3.1. Obesity and Diet Management Apps
        • 5.1.2.3.2. Diabetes and Blood Glucose Tracking Apps
      • 5.1.2.4. Services
    • 5.1.3. By Device Type
      • 5.1.3.1. Handheld Devices
      • 5.1.3.2. Wearable Devices
    • 5.1.4. By Patient Type
      • 5.1.4.1. Type 1 Diabetes
      • 5.1.4.2. Type 2 Diabetes
    • 5.1.5. By End-user
      • 5.1.5.1. Home Healthcare
      • 5.1.5.2. Hospitals and Specialty Clinics
      • 5.1.5.3. Academic and Research Institutes
      • 5.1.5.4. Others
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
        • 5.1.6.1.1. By Value
        • 5.1.6.1.2. By Volume
      • 5.1.6.2. By Products and Services
        • 5.1.6.2.1. Devices
          • 5.1.6.2.1.1. Smart Insulin Pens
          • 5.1.6.2.1.2. Smart Glucose Meters
          • 5.1.6.2.1.3. Smart Insulin Pumps
          • 5.1.6.2.1.4. Continuous Blood Glucose Monitoring (CGM) System
        • 5.1.6.2.2. Data Management Software and Platform
        • 5.1.6.2.3. Diabetes Applications
          • 5.1.6.2.3.1. Obesity and Diet Management Apps
          • 5.1.6.2.3.2. Diabetes and Blood Glucose Tracking Apps
        • 5.1.6.2.4. Services
      • 5.1.6.3. By Device Type
        • 5.1.6.3.1. Handheld Devices
        • 5.1.6.3.2. Wearable Devices
      • 5.1.6.4. By Patient Type
        • 5.1.6.4.1. Type 1 Diabetes
        • 5.1.6.4.2. Type 2 Diabetes
      • 5.1.6.5. By End-user
        • 5.1.6.5.1. Home Healthcare
        • 5.1.6.5.2. Hospitals and Specialty Clinics
        • 5.1.6.5.3. Academic and Research Institutes
        • 5.1.6.5.4. Others
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Products and Services
  • 6.2. By Device Type
  • 6.3. By Patient Type
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat From New Entrants
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Patent Landscape
  • 9.2. Regulatory Approvals
  • 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Dexcom, Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. F. Hoffmann-La Roche Ltd
  • 13.3. Abbott Laboratories
  • 13.4. Medtronic
  • 13.5. B. Braun SE
  • 13.6. Tandem Diabetes Care, Inc.
  • 13.7. LifeScan, Inc.
  • 13.8. Insulet Corporation
  • 13.9. Bayer AG
  • 13.10. Ascensia Diabetes Care Holdings AG

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 4. Global Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 5. Global Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 6. Global Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Digital Diabetes Management Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 10. North America Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 11. North America Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 12. North America Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 13. North America Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Digital Diabetes Management Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 17. United States Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 18. United States Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 19. United States Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 20. United States Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 23. Canada Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 24. Canada Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 25. Canada Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 26. Canada Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 29. Mexico Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 30. Mexico Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 31. Mexico Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 32. Mexico Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Europe Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 36. Europe Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 37. Europe Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 38. Europe Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Digital Diabetes Management Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 42. Germany Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 43. Germany Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 44. Germany Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 45. Germany Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. France Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 49. France Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 50. France Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 51. France Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 54. Italy Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 55. Italy Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 56. Italy Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 57. Italy Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 60. United Kingdom Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 61. United Kingdom Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 62. United Kingdom Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 63. United Kingdom Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Russia Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 67. Russia Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 68. Russia Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 69. Russia Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 72. Netherlands Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 73. Netherlands Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 74. Netherlands Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 75. Netherlands Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 78. Spain Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 79. Spain Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 80. Spain Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 81. Spain Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 84. Turkey Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 85. Turkey Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 86. Turkey Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 87. Turkey Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Poland Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 91. Poland Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 92. Poland Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 93. Poland Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. South America Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 97. South America Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 98. South America Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 99. South America Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Digital Diabetes Management Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 103. Brazil Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 104. Brazil Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 105. Brazil Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 106. Brazil Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 109. Argentina Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 110. Argentina Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 111. Argentina Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 112. Argentina Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 115. Asia-Pacific Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 116. Asia-Pacific Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 117. Asia-Pacific Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 118. Asia-Pacific Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Digital Diabetes Management Market Share (%), By Country, 2017-2031F
  • Figure 120. India Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 122. India Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 123. India Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 124. India Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 125. India Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 128. China Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 129. China Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 130. China Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 131. China Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 134. Japan Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 135. Japan Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 136. Japan Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 137. Japan Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 140. Australia Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 141. Australia Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 142. Australia Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 143. Australia Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Vietnam Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 147. Vietnam Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 148. Vietnam Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 149. Vietnam Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 152. South Korea Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 153. South Korea Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 154. South Korea Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 155. South Korea Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 158. Indonesia Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 159. Indonesia Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 160. Indonesia Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 161. Indonesia Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 164. Philippines Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 165. Philippines Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 166. Philippines Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 167. Philippines Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 170. Middle East & Africa Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 171. Middle East & Africa Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 172. Middle East & Africa Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 173. Middle East & Africa Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Digital Diabetes Management Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Saudi Arabia Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 178. Saudi Arabia Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 179. Saudi Arabia Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 180. Saudi Arabia Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. UAE Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 184. UAE Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 185. UAE Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 186. UAE Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Digital Diabetes Management Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Digital Diabetes Management Market, By Volume, In Million Units, 2017-2031F
  • Figure 189. South Africa Digital Diabetes Management Market Share (%), By Products and Services, 2017-2031F
  • Figure 190. South Africa Digital Diabetes Management Market Share (%), By Device Type, 2017-2031F
  • Figure 191. South Africa Digital Diabetes Management Market Share (%), By Patient Type, 2017-2031F
  • Figure 192. South Africa Digital Diabetes Management Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Products and Services Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Device Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Patient Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023